English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
-
Global Logistics
As long as you buy our products, no matter where you are, will give you the best logistics service.
-
Mechanical automation
Committed to making construction work easier, faster and safer.
-
System perfection
builds a better future through sustainable and innovative solutions.
-
Professional technical personnel
Our employees deliver technology leading products, systems, software and services to our customers.
![99% USP Creatinine for Liver Protection/Amino Acid Derivatives/ API CAS60]()
99% USP Creatinine for Liver Protection/Amino Acid Derivatives/ API CAS60![Glucose Dextrose Injection 5% 1000ml Intravenous Infusion Medicine Supplier]()
Glucose Dextrose Injection 5% 1000ml Intravenous Infusion Medicine Supplier![33419]()
33419![Hot Sale Getein 1100 Fluorescence Immunoassay for Diabetic Nephropathy and Hypertensive Nephropathy]()
Hot Sale Getein 1100 Fluorescence Immunoassay for Diabetic Nephropathy and Hypertensive Nephropathy![Raw China Antidepressant Powder Chemical Tianeptine Sodium/Tianeptine Sulfate/Nootropic Phenibut Pharmaceutical Grade API 99% Purity Sodium Tianeptine]()
Raw China Antidepressant Powder Chemical Tianeptine Sodium/Tianeptine Sulfate/Nootropic Phenibut Pharmaceutical Grade API 99% Purity Sodium Tianeptine![Good Quality HDPE Geo]()
Good Quality HDPE Geo![Ribavirin Injection Antiviral Drug GMP Plant]()
Ribavirin Injection Antiviral Drug GMP Plant![Vemurafenib 918504]()
Vemurafenib 918504
Shenzhen Rivaroxaban Co.,Ltd
Shenzhen Rivaroxaban Co.,Ltd is a leading pharmaceutical company that focuses on the production of Rivaroxaban, Pharmaceutical Intermediates, Tegprazan, and VeMurafenib. We have a team of skilled and experienced researchers who have helped us to produce high-quality products that meet the needs of our clients.We have invested heavily in the latest
Rich industry experience
The company was founded in 1941 by brothers Eugen and Martin Hilti.
Advanced technology
Transform lives, shape tomorrow. Embrace the future
Full service
Simplify your life. Comprehensive support. Superior quality.
-
Nov 05, 2023FDA Approves First Anti
The Food and Drug Administration (FDA) has approved the first-ever anti-inflammatory drug for cardiovascular disease. Ca
read more -
Sep 29, 2023Lower Doses of Statins Just as Effective in Older Adults Who Are at Greater Risk of Side Effects from the Cholesterol Drugs
When adults are found to have high levels LDL—the form of cholesterol that can raise the risk of stroke and heart attack
read more -
Aug 22, 2023Association of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI
Cardiovascular Diabetology volume 22, Article number: 201 (2023) Cite this article 24 Accesses 1 Altmetric Metrics detai
read more -
Aug 22, 2023Stroke, Clot Risk Halved When Apixaban Taken Versus Rivaroxaban
Frank Otto C: 267-693-2999 [email protected] For Patients and the General Public: 1-800-789-7366 For M
read more -
Nov 23, 2023
-
Nov 09, 2023Daily briefing: Fighting leishmaniasis, a disease causing terrible scars in Sudan
You can also search for this author in PubMed Google Scholar You have full access to this article via your institution. Hello Nature readers, would you like to get this Briefing in your inbox free
read more -
Oct 27, 2023G20 Health Ministers call for building resilient, equitable access to affordable medicines in developing world, ET HealthWorld
According to the outcome document released after the meet in Gandhinagar on August 19, consensus was built on setting up research and development and manufacturing network for vaccines, therapeutics,
read more -
Oct 13, 2023Wegovy shown to reduce risk of heart attack, stroke in major cardiovascular trial
The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people with cardiovascular disease,
read more